Executive DirectorCSL BehringKing of Prussia, Pennsylvania, United States
PB1090 - Modelling the effects of 4-factor prothrombin complex concentrate for the management of factor Xa inhibitor-associated bleeding
Tuesday, June 27, 202318:30 – 19:30 ET